Adrenal Insufficiency Secondary to Abrupt Dose Reduction of Topical Corticosteroid Therapy after Starting Brodalumab for Psoriasis: A Case Report

The risk of treating psoriasis with biologic drugs in patients treated with topical corticosteroids over prolonged periods requires careful attention to their underlying adrenal insufficiency because the development of adrenal insufficiency symptoms frequently occurs after cessation of the topical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamane, Mariko, Hayashi, Hiroaki, Aoyama, Yumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995656/
https://www.ncbi.nlm.nih.gov/pubmed/35496509
http://dx.doi.org/10.1159/000523802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995656/
https://www.ncbi.nlm.nih.gov/pubmed/35496509
http://dx.doi.org/10.1159/000523802

Ejemplares similares